Diethylaminopropionamido‐hydroxy‐anthraquinones as Potential Anticancer Agents : Synthesis and Characterization
- 1 January 1989
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 322 (9), 541-544
- https://doi.org/10.1002/ardp.19893220906
Abstract
A number of new 9,10-anthracenediones were obtained, bearing one or two hydroxyl groups and one positively charged side chain at different positions of the aromatic ring system (compounds 1-5 in Chart 1). These derivatives resemble the anticancer agents mitoxantrone and ametantrone. The synthesis started from dihydroxy- or amino-hydroxy-9,10-anthracenediones, which were converted into the nitro-derivatives. After reduction to the corresponding amines and acylation with 3-chloropropionyl chloride, substitution with diethylamine led to the final diethylaminopropionamido derivatives. The new anthracenediones cause a quite relevant inhibition of cell growth in vitro and will be tested as possible anticancer agents.Keywords
This publication has 7 references indexed in Scilit:
- Mitoxantrone: an active, new antitumor agent with an improved therapeutic indexCancer Treatment Reviews, 1987
- Mitoxantrone: A New Anticancer Drug with Significant Clinical ActivityAnnals of Internal Medicine, 1986
- Drug Disposition and PharmacologyPublished by Springer Science and Business Media LLC ,1984
- New anthracenedione derivatives: Interaction with DNA and biological effectsChemico-Biological Interactions, 1983
- 2 The Design, Synthesis and Development of a New Class of Potent Antineoplastic AnthraquinonesProgress in Medicinal Chemistry, 1983
- 3 Adriamycin and Related Anthracycline AntibioticsProgress in Medicinal Chemistry, 1978
- CARDIAC TOXICITY OF DAUNORUBICINThe Lancet, 1969